UNITED THERAPEUTICS Corp (UTHR)
About UNITED THERAPEUTICS Corp
United Therapeutics Corp specializes in drug development for pulmonary arterial hypertension (PAH), a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. The company markets and sells the following commercial therapies in the United States to treat PAH: Tyvaso DPI (treprostinil) Inhalation Powder, Remodulin Injection, Orenitram (treprostinil) Extended-Release Tablets, Adcirca (tadalafil) Tablets, and Unituxin. It derives maximum revenue from the sale of Tyvaso DPI. Geographically, the company operates in United States and Rest of the World, of which United States generates majority of the revenue.
This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.
Financial summary
- Revenue FY2025
- $3.2B
- Net income
- $1.3B
- Total assets
- $7.9B
- Market cap
- $26.3B
Source: SEC EDGAR · updated Jun 7, 2026
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $26.3B
- Shares outstanding
- 44.4M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Jun 17, 1999
UNITED THERAPEUTICS Corp (UTHR) Stock Price
- Profitable — net income of $1.3B in FY2025.
- Trading near its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review UNITED THERAPEUTICS Corp.
Write a review
News about UNITED THERAPEUTICS Corp
News & sentiment via Polygon.io
UNITED THERAPEUTICS Corp: frequently asked questions
Is UNITED THERAPEUTICS Corp an American company?
Yes — UNITED THERAPEUTICS Corp is an American company. UNITED THERAPEUTICS Corp is incorporated in Delaware, United States and headquartered in Silver Spring, Maryland. Its legal-entity record reports no foreign parent — the company is independently American-owned.
Where is UNITED THERAPEUTICS Corp incorporated?
UNITED THERAPEUTICS Corp is legally incorporated in Delaware, United States, according to its GLEIF legal-entity record.
Who owns UNITED THERAPEUTICS Corp?
UNITED THERAPEUTICS Corp reports no parent company in its legal-entity record — it is independently owned rather than a subsidiary.
Is UNITED THERAPEUTICS Corp traded on a US stock exchange?
Yes — UNITED THERAPEUTICS Corp trades under the ticker UTHR on the NASDAQ.
Where is UNITED THERAPEUTICS Corp headquartered?
UNITED THERAPEUTICS Corp is headquartered in Silver Spring, Maryland, United States.
Is UNITED THERAPEUTICS Corp publicly traded?
Yes — UNITED THERAPEUTICS Corp is a publicly traded company. Its stock trades under the ticker symbol UTHR on the NASDAQ.
What does UNITED THERAPEUTICS Corp do?
UNITED THERAPEUTICS Corp is an American Pharmaceuticals company in the Health & Beauty sector.
